| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 146, Issue 9 3012-3017, Copyright © 1991 by American Association of Immunologists
ARTICLES |
MK Racke, S Dhib-Jalbut, B Cannella, PS Albert, CS Raine and DE McFarlin
Neuroimmunology Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD 30892.
Experimental allergic encephalomyelitis (EAE) is an autoimmune disease characterized by inflammation and demyelination in the central nervous system. The effect of the immunosuppressive molecule transforming growth factor-beta, (TGF-beta 1) on chronic relapsing EAE produced by the transfer of myelin basic protein-specific T cell lines was studied. TGF-beta 1 markedly inhibited the activation and proliferation of myelin-basic protein-specific lymph node cells in vitro. This reduced the capacity of these cells to transfer EAE. In addition, administration of TGF-beta 1 in vivo consistently resulted in an improved clinical course, even when given during ongoing disease. Immunopathologic study demonstrated a marked reduction in central nervous system damage and expression of cell-surface lymphocyte function-associated Ag-1 and class II MHC molecules in TGF-beta 1- treated mice. These findings have identified TGF-beta 1 as a possible therapeutic agent for the human demyelinating disease multiple sclerosis.
This article has been cited by other articles:
|
|
 |
|
  L. Das and A. D. Levine TGF-{beta} Inhibits IL-2 Production and Promotes Cell Cycle Arrest in TCR-Activated Effector/Memory T Cells in the Presence of Sustained TCR Signal Transduction J. Immunol., February 1, 2008; 180(3): 1490 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Makwana, L. L. Jones, D. Cuthill, H. Heuer, M. Bohatschek, M. Hristova, S. Friedrichsen, I. Ormsby, D. Bueringer, A. Koppius, et al. Endogenous Transforming Growth Factor {beta}1 Suppresses Inflammation and Promotes Survival in Adult CNS J. Neurosci., October 17, 2007; 27(42): 11201 - 11213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Preller, A. Gerber, S. Wrenger, M. Togni, D. Marguet, J. Tadje, U. Lendeckel, C. Rocken, J. Faust, K. Neubert, et al. TGF-beta1-Mediated Control of Central Nervous System Inflammation and Autoimmunity through the Inhibitory Receptor CD26 J. Immunol., April 1, 2007; 178(7): 4632 - 4640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gold, C. Linington, and H. Lassmann Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research Brain, August 1, 2006; 129(8): 1953 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Murano, X. Xiong, N. Murano, J. L. Salzer, J. J. Lafaille, and V. K. Tsiagbe Latent TGF-{beta}1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis J. Leukoc. Biol., January 1, 2006; 79(1): 140 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.S. Prime, M. Pring, M. Davies, and I.C. Paterson TGF-{beta} SIGNAL TRANSDUCTION IN ORO-FACIAL HEALTH AND NON-MALIGNANT DISEASE (PART I) Crit. Rev. Oral. Biol. Med., November 1, 2004; 15(6): 324 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Klein, L. Izikson, T. Means, H. D. Gibson, E. Lin, R. A. Sobel, H. L. Weiner, and A. D. Luster IFN-Inducible Protein 10/CXC Chemokine Ligand 10-Independent Induction of Experimental Autoimmune Encephalomyelitis J. Immunol., January 1, 2004; 172(1): 550 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, P. B. Silver, T. K. Tarrant, C.-C. Chan, and R. R. Caspi TGF-{beta} Inhibits Activation and Uveitogenicity of Primary but Not of Fully Polarized Retinal Antigen-Specific Memory-Effector T Cells Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4805 - 4812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Denkinger, M. Denkinger, J. J. Kort, C. Metz, and T. G. Forsthuber In Vivo Blockade of Macrophage Migration Inhibitory Factor Ameliorates Acute Experimental Autoimmune Encephalomyelitis by Impairing the Homing of Encephalitogenic T Cells to the Central Nervous System J. Immunol., February 1, 2003; 170(3): 1274 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Flanders and J. K. Burmester Medical Applications of Transforming Growth Factor-{beta} Clin. Med. Res., January 1, 2003; 1(1): 13 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.B. Sugerman, N.W. Savage, L.J. Walsh, Z.Z. Zhao, X.J. Zhou, A. Khan, G.J. Seymour, and M. Bigby THE PATHOGENESIS OF ORAL LICHEN PLANUS Crit. Rev. Oral. Biol. Med., July 1, 2002; 13(4): 350 - 365. [Abstract] [Full Text]
|
|
|
|
|
|
H. Braley-Mullen, K. Chen, Y. Wei, and S. Yu Role of TGF{beta} in Development of Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice J. Immunol., December 15, 2001; 167(12): 7111 - 7118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Forsthuber, C. L. Shive, W. Wienhold, K. de Graaf, E. G. Spack, R. Sublett, A. Melms, J. Kort, M. K. Racke, and R. Weissert T Cell Epitopes of Human Myelin Oligodendrocyte Glycoprotein Identified in HLA-DR4 (DRB1*0401) Transgenic Mice Are Encephalitogenic and Are Presented by Human B Cells J. Immunol., December 15, 2001; 167(12): 7119 - 7125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Duran, E M Martinez-Caceres, L Brieva, M Tintore, and X Montalban Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis Multiple Sclerosis, June 1, 2001; 7(3): 151 - 156. [Abstract] [PDF]
|
|
|
|
|
|
J. L. Croxford, M. Feldmann, Y. Chernajovsky, and D. Baker Different Therapeutic Outcomes in Experimental Allergic Encephalomyelitis Dependant Upon the Mode of Delivery of IL-10: A Comparison of the Effects of Protein, Adenoviral or Retroviral IL-10 Delivery into the Central Nervous System J. Immunol., March 15, 2001; 166(6): 4124 - 4130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Steinbrecher, D. Reinhold, L. Quigley, A. Gado, N. Tresser, L. Izikson, I. Born, J. Faust, K. Neubert, R. Martin, et al. Targeting Dipeptidyl Peptidase IV (CD26) Suppresses Autoimmune Encephalomyelitis and Up-Regulates TGF-{{beta}}1 Secretion In Vivo J. Immunol., February 1, 2001; 166(3): 2041 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Cannella, D. Pitt, E. Capello, and C. S. Raine Insulin-Like Growth Factor-1 Fails to Enhance Central Nervous System Myelin Repair during Autoimmune Demyelination Am. J. Pathol., September 1, 2000; 157(3): 933 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Rohowsky-Kochan, D Molinaro, and S D Cook Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis Multiple Sclerosis, April 1, 2000; 6(2): 69 - 77. [Abstract] [PDF]
|
|
|
|
|
|
D. A. Young, L. D. Lowe, S. S. Booth, M. J. Whitters, L. Nicholson, V. K. Kuchroo, and M. Collins IL-4, IL-10, IL-13, and TGF-{beta} from an Altered Peptide Ligand-Specific Th2 Cell Clone Down-Regulate Adoptive Transfer of Experimental Autoimmune Encephalomyelitis J. Immunol., April 1, 2000; 164(7): 3563 - 3572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Drescher, P. D. Murray, X. Lin, J. A. Carlino, and M. Rodriguez TGF-{beta}2 Reduces Demyelination, Virus Antigen Expression, and Macrophage Recruitment in a Viral Model of Multiple Sclerosis J. Immunol., March 15, 2000; 164(6): 3207 - 3213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kobayashi, K. Yoshida, J. M. Ward, J. J. Letterio, G. Longenecker, L. Yaswen, B. Mittleman, E. Mozes, A. B. Roberts, S. Karlsson, et al. {beta}2-Microglobulin-Deficient Background Ameliorates Lethal Phenotype of the TGF-{beta}1 Null Mouse J. Immunol., October 1, 1999; 163(7): 4013 - 4019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ishikawa, Y. Jin, H. Guo, H. Link, and B.-G. Xiao Nasal administration of transforming growth factor-{beta}1 induces dendritic cells and inhibits protracted-relapsing experimental allergic encephalomyelitis Multiple Sclerosis, June 1, 1999; 5(3): 184 - 191. [Abstract] [PDF]
|
|
|
|
|
|
G V McDonnell, C W Kirk, S A Hawkins, and C A Graham Lack of association of transforming growth factor (TGF)-b1 and b2 gene polymorphisms with multiple sclerosis (MS) in Northern Ireland Multiple Sclerosis, April 1, 1999; 5(2): 105 - 109. [Abstract] [PDF]
|
|
|
|
|
|
R. K. Agarwal, C.-C. Chan, B. Wiggert, and R. R. Caspi Pregnancy Ameliorates Induction and Expression of Experimental Autoimmune Uveitis J. Immunol., March 1, 1999; 162(5): 2648 - 2654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. R. BUCCELLATO, M. MILOSO, M. BRAGA, G. NICOLINI, A. MORABITO, G. PRAVETTONI, G. TREDICI, and G. SCALABRINO Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-{alpha}-mediated FASEB J, February 1, 1999; 13(2): 297 - 304. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Chen, W. Jin, and S. M. Wahl Engagement of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA-4) Induces Transforming Growth Factor beta (TGF-beta ) Production by Murine CD4+ T Cells J. Exp. Med., November 16, 1998; 188(10): 1849 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Constantinescu, M. Wysocka, B. Hilliard, E. S. Ventura, E. Lavi, G. Trinchieri, and A. Rostami Antibodies Against IL-12 Prevent Superantigen-Induced and Spontaneous Relapses of Experimental Autoimmune Encephalomyelitis J. Immunol., November 1, 1998; 161(9): 5097 - 5104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Begolka, C. L. Vanderlugt, S. M. Rahbe, and S. D. Miller Differential Expression of Inflammatory Cytokines Parallels Progression of Central Nervous System Pathology in Two Clinically Distinct Models of Multiple Sclerosis J. Immunol., October 15, 1998; 161(8): 4437 - 4446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Z. Chen, G. M. Hochwald, C. Huang, G. Dakin, H. Tao, C. Cheng, W. J. Simmons, G. Dranoff, and G. J. Thorbecke Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta 1 PNAS, October 13, 1998; 95(21): 12516 - 12521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Gorham, M. L. Guler, D. Fenoglio, U. Gubler, and K. M. Murphy Low Dose TGF-{beta} Attenuates IL-12 Responsiveness in Murine Th Cells J. Immunol., August 15, 1998; 161(4): 1664 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Issazadeh, V. Navikas, M. Schaub, M. Sayegh, and S. Khoury Kinetics of Expression of Costimulatory Molecules and Their Ligands in Murine Relapsing Experimental Autoimmune Encephalomyelitis In Vivo J. Immunol., August 1, 1998; 161(3): 1104 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. K. Shreedhar, M. W. Pride, Y. Sun, M. L. Kripke, and F. M. Strickland Origin and Characteristics of Ultraviolet-B Radiation-Induced Suppressor T Lymphocytes J. Immunol., August 1, 1998; 161(3): 1327 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Cantorna, W. D. Woodward, C. E. Hayes, and H. F. DeLuca 1,25-Dihydroxyvitamin D3 Is a Positive Regulator for the Two Anti-Encephalitogenic Cytokines TGF-{beta}1 and IL-4 J. Immunol., June 1, 1998; 160(11): 5314 - 5319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Martiney, A. J. Rajan, P. C. Charles, A. Cerami, P. C. Ulrich, S. Macphail, K. J. Tracey, and C. F. Brosnan Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by CNI-1493, a Macrophage-Deactivating Agent J. Immunol., June 1, 1998; 160(11): 5588 - 5595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Croxford, K. Triantaphyllopoulos, O. L. Podhajcer, M. Feldmann, D. Baker, and Y. Chernajovsky Cytokine Gene Therapy in Experimental Allergic Encephalomyelitis by Injection of Plasmid DNA-Cationic Liposome Complex into the Central Nervous System J. Immunol., May 15, 1998; 160(10): 5181 - 5187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brunetti, A. Colasante, N. Mascetra, M. Piantelli, P. Musiani, and F. B. Aiello IL-10 Synergizes with Dexamethasone in Inhibiting Human T Cell Proliferation J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 915 - 919. [Abstract] [Full Text]
|
|
|
|
|
|
D. Zeng, M. Dick, L. Cheng, M. Amano, S. Dejbakhsh-Jones, P. Huie, R. Sibley, and S. Strober Subsets of Transgenic T Cells That Recognize CD1 Induce or Prevent Murine Lupus: Role of Cytokines J. Exp. Med., February 16, 1998; 187(4): 525 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. McManus, C. F. Brosnan, and J. W. Berman Cytokine Induction of MIP-1{alpha} and MIP-1{beta} in Human Fetal Microglia J. Immunol., February 1, 1998; 160(3): 1449 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Shaw, J. B. Lorens, A. Dhawan, R. DalCanto, H. Y. Tse, A. B. Tran, C. Bonpane, S. L. Eswaran, S. Brocke, N. Sarvetnick, et al. Local Delivery of Interleukin 4 by Retrovirus-Transduced T Lymphocytes Ameliorates Experimental Autoimmune Encephalomyelitis J. Exp. Med., May 5, 1997; 185(9): 1711 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Critchfield, M. Racke, J. Zuniga-Pflucker, B Cannella, C. Raine, J Goverman, and M. Lenardo T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis Science, February 25, 1994; 263(5150): 1139 - 1143. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Del Giudice and M. K. Crow Review: Role of Transforming Growth Factor Beta (TGF{beta}) in Systemic Autoimmunity Lupus, August 1, 1993; 2(4): 213 - 220. [Abstract] [PDF]
|
|
|
|
|
|
D.-R. Koh, W.-P. Fung-Leung, A. Ho, D. Gray, H. Acha-Orbea, and T.-W. Mak Less Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8-/- Mice Science, May 22, 1992; 256(5060): 1210 - 1213. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
